retatrutide type 2 diabetes phase 2 results 2024 2025 Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released trial demonstrating 25% weight loss in half of people with #obesity. This amount of weight loss has not been accomplished Test results on a popular

If your formulation does not include B12, supplement separately

When to seek help Contact your clinic or a doctor if you have severe or escalating pain, swelling that worsens after several days rather than improving, signs of infection (pus, spreading redness, fever), unusual skin discolouration, or lumps that persist beyond three to four weeks

Trusted by 50,000+ GLP-1 users No spam, ever Why Sleep Is Critical for Weight Loss on GLP-1s Getting adequate, restful sleep isn't just about feeling good the next day it's a critical component of your metabolic health journey

(New Taipei City, Taiwan)

If you are struggling with weight management or diabetes and are interested in how these medications might fit into your rehabilitation or wellness plan, our team at Cape Fear Physical Medicine and Rehab is here to guide you through your options with evidence-based, compassionate care